ArticleBMC psychiatry2026
Psychiatric comorbidity in functional tics: a scoping review.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThere has been a dramatic rise in the prevalence of functional tics since the COVID-19 pandemic. While the prevalence of various comorbidities has been well defined in primary tic disorders such as Tourette Syndrome, less is known about this topic in patients with functional tics. Therefore, the purpose of this scoping review is to characterize what is known about the prevalence of psychiatric and neurologic comorbidities in patients with functional tics and identify gaps that persist in this literature.
methodsA comprehensive search across multiple databases was used for data collection. We included studies that provided original data on the presence of psychiatric comorbidities in patients with a diagnosis of functional tics. Study screening progress was documented in a Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow chart. A total of 150 titles and abstracts were screened, 78 full texts were evaluated for eligibility, and 31 studies were included.
resultsThe included studies identified epidemiological data and common psychiatric and neurologic comorbidities in patients with functional tics. Most of the studies reviewed were published after 2020, highlighting the recent uptick in incidence and prevalence of functional tics. Depression and anxiety, followed by attention deficit hyperactivity disorder and obsessive-compulsive disorder, were among the most commonly identified comorbidities.
conclusionsOverall, further research on the prevalence of comorbidities in patients with functional tics is needed to inform clinicians’ differential diagnosis and integrated treatment planning. Depression and anxiety are common comorbidities in patients with functional tics and may be underrecognized and underreported. The prevalence of all comorbidities appears to have increased since the COVID-19 pandemic. Future research should further quantitatively define the comorbidity profile in functional tics. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.